Business Standard | Cadila to launch new affordable lung cancer drug soon Moneycontrol.com India has nearly 50,000 new cases of lung cancer every year and Cadila hopes the competitively priced Mycidac-C, which is available at almost one-tenth the cost of existing therapies will be able to make a dent in the Rs 300 crore market for lung ... Gujarat pharma firms vie for share in cancer drug space |
